World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
45294
World Ranking
1141
National Ranking
29

Medicine

D-Index
88
Citations
45342
World Ranking
12921
National Ranking
179

Cem Gabay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cem Gabay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 408 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cem Gabay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cem Gabay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Cem Gabay is affiliated with the University of Geneva in Switzerland and works primarily within the fields of Medicine and Immunology and Microbiology. Their research spans various subfields, including Immunology, Rheumatology, Molecular Biology, Hematology, and Infectious Diseases.

Their main research topics cover a range of immune-related conditions and mechanisms, including:

  • Inflammasome and immune disorders
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • IL-33, ST2, and ILC Pathways
  • Monoclonal and Polyclonal Antibodies Research
  • Immune Cell Function and Interaction

Their publication record includes articles in various scientific journals and venues. Frequent publication venues for their work include:

  • Revue Médicale Suisse
  • Arthritis & Rheumatology
  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Lara D. Veeken

Some of the recent papers by Cem Gabay are:

  • Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial, 2020, The Lancet
  • Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis, 2020, Arthritis Research & Therapy
  • The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries, 2020, Lara D. Veeken
  • Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail, 2020, Clinical Pharmacology & Therapeutics
  • Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland, 2020, RMD Open

Cem Gabay frequently collaborates with a number of co-authors, including:

  • Charlotte Girard
  • Axel Finckh
  • Emiliana Rodriguez
  • Denis Mongin
  • Céline Lamacchia

Best Publications

  • Acute-phase proteins and other systemic responses to inflammation.

    Unknown

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • Interleukin-6 and chronic inflammation.

    Cem Gabay

  • INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology

    William P. Arend;Mark Malyak;Carla J. Guthridge;Cem Gabay

  • IL‐1, IL‐18, and IL‐33 families of cytokines

    William P. Arend;Gaby Palmer;Cem Gabay

  • IL-1 pathways in inflammation and human diseases

    Cem Gabay;Céline Lamacchia;Gaby Palmer

  • Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

    Cem Gabay;Paul Emery;Ronald van Vollenhoven;Ara Dikranian

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

  • EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

    Danielle M. Gerlag;Karim Raza;Lisa G M van Baarsen;Elisabeth Brouwer

  • The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases

    Jennifer Palomo;Damien Dietrich;Praxedis Martin;Gaby Palmer

  • Leptin Signaling Deficiency Impairs Humoral and Cellular Immune Responses and Attenuates Experimental Arthritis

    Nathalie Busso;Alexander So;Véronique Chobaz-Péclat;Carole Morard

  • Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

    Gaby Palmer;Dominique Talabot-Ayer;Céline Lamacchia;Dean Toy

  • Leptin deficiency enhances sensitivity to endotoxin-induced lethality

    Raffaella Faggioni;Giamila Fantuzzi;Cem Gabay;Arthur Moser

  • IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

    Christoph A. Meier;Elisabetta Bobbioni;Cem Gabay;Françoise Assimacopoulos-Jeannet

  • Prevotella copri in individuals at risk for rheumatoid arthritis.

    Deshire Alpizar-Rodriguez;Till Robin Lesker;Achim Gronow;Benoît Gilbert

  • Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.

    David Moulin;Olivier Donzé;Dominique Talabot-Ayer;Françoise Mézin

  • Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome

    Eric S. Weiss;Charlotte Girard-Guyonvarc’h;Dirk Holzinger;Dirk Holzinger;Adriana A. de Jesus

  • Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

    Glynn Dennis;Cécile T J Holweg;Sarah K Kummerfeld;David F Choy

  • IL-36R ligands are potent regulators of dendritic and T cells

    Solenne Vigne;Gaby Palmer;Céline Lamacchia;Praxedis Martin

  • Anti‐cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis

    S Bas;S Genevay;O Meyer;C Gabay

  • CD14 Is an Acute-Phase Protein

    Sylvette Bas;Benoit R. Gauthier;Ursula Spenato;Sybille Stingelin

  • Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (vol 381, pg 1541, 2013)

    C. Gabay;P. Emery;R. van Vollenhoven

Frequent Co-Authors

Gaby Palmer
Gaby Palmer University of Geneva
Karel Pavelka
Karel Pavelka Charles University
Tore K. Kvien
Tore K. Kvien University of Oslo
Paul Emery
Paul Emery University of Leeds
Juan J. Gomez-Reino
Juan J. Gomez-Reino University of Santiago de Compostela
Ronald F. van Vollenhoven
Ronald F. van Vollenhoven University of Amsterdam
Maxime Dougados
Maxime Dougados Hôpital Cochin
Gerd R. Burmester
Gerd R. Burmester Charité - University Medicine Berlin
Jean-Michel Dayer
Jean-Michel Dayer University of Geneva
Dominique Baeten
Dominique Baeten University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA can open the door to diverse healthcare and research careers, often intersecting with nursing and clinical sciences. Many students explore accelerated pathways to combine their immunology background with advanced nursing roles. For example, those interested in nursing can benefit from enrolling in accelerated RN to NP programs, which fast-track registered nurses to nurse practitioner roles.

For nurses aiming to specialize further, acute care certification for FNP professionals offers a focused credential essential for managing critically ill patients, aligning well with immunology expertise related to immune responses and infectious diseases.

Prospective students without a nursing background might consider exploring the best online RN programs for non nurses. These programs provide a solid clinical foundation while offering flexibility for those transitioning from science-based fields like immunology.

Additionally, those looking for quicker entry into nursing can look into the easiest ABSN programs to get into. These accelerated programs allow individuals to earn a Bachelor of Science in Nursing efficiently, creating more career options in healthcare, including immunology-related clinical settings.

Best Scientists Citing Cem Gabay

Trending Scientists

Recently Published Articles